أعرض في EDS

Targeted Microglial Attenuation through Dendrimer–Drug Conjugates Improves Glaucoma Neuroprotection

التفاصيل البيبلوغرافية
العنوان: Targeted Microglial Attenuation through Dendrimer–Drug Conjugates Improves Glaucoma Neuroprotection
المؤلفون: Ian Pitha, Siva Kambhampati, Anjali Sharma, Rishi Sharma, Liam McCrea, Ann Mozzer, Rangaramanujam M. Kannan
المصدر: Biomacromolecules
بيانات النشر: American Chemical Society (ACS), 2023.
سنة النشر: 2023
مصطلحات موضوعية: Biomaterials, Polymers and Plastics, Materials Chemistry, Bioengineering, Article
الوصف: Retinal microglial/macrophage activation and optic nerve (ON) microglial/macrophage activation are glaucoma biomarkers and potential therapeutic targets for this blinding disease. We report targeting of activated microglia by PAMAM dendrimers in a rat glaucoma model and neuroprotection by N-acetylcysteine-conjugated dendrimer (D-NAC) conjugates in a post-injury rescue experiment. Intravitreally delivered fluorescently labeled dendrimer (D-Cy5) conjugates targeted and were retained in Iba-1-positive cells (90% at 7 days and 55% after 28 days) in the retina following intraocular pressure (IOP) elevation, while systemically delivered D-Cy5 targeted ON cells. A single intravitreal D-NAC dose given 1 week after IOP elevation significantly reduced transcription of pro-inflammatory (IL-6, MCP-1, IL-1β) and A1 astrocyte (Serping1, Fkbp5, Amigo2) markers and increased survival of retinal ganglion cells (39 ± 12%) versus BSS- (20 ± 15%, p = 0.02) and free NAC-treated (26 ± 14%, p = 0.15) eyes. These results highlight the potential of dendrimer-targeted microglia and macrophages for early glaucoma detection and as a neuroprotective therapeutic target.
تدمد: 1526-4602
1525-7797
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::244e7d4459b73667032be102a3090857
https://doi.org/10.1021/acs.biomac.2c01381
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....244e7d4459b73667032be102a3090857
قاعدة البيانات: OpenAIRE
الوصف
تدمد:15264602
15257797